Top Story

Laparoscopic radical cystectomy conferred favorable long-term survival outcomes

December 29, 2014

Patients with muscle-invasive or high-risk bladder cancer experienced favorable RFS, OS and cancer-specific survival outcomes after undergoing laparoscopic radical cystectomy, according to retrospective study results.

The survival outcomes associated with the laparoscopic procedure were comparable to those previously reported with open radical cystectomy, results showed.

VALOR: Vosaroxin combination provides ‘potential new agent’ for treatment of AML Meeting News CoverageVideo

VALOR: Vosaroxin combination provides ‘potential new agent’ for treatment of AML

December 28, 2014
SAN FRANCISCO — Mark R. Litzow, MD, professor of medicine at Mayo Clinic and chair of the ECOG-ACRIN Leukemia Committee, highlights data demonstrating that…
Updated clinical data may significantly impact impact treatment of CLL Meeting News CoverageVideo

Updated clinical data may significantly impact impact treatment of CLL

December 27, 2014
SAN FRANCISCO — Jeffrey P. Sharman, MD, medical director of hematology research at US Oncology Research, discusses key updates of previously released clinical…
In the Journals

Acid reflux medications may extend survival in HNSCC

December 26, 2014
Two types of antacid medications commonly used by patients with head and neck squamous cell carcinoma to reduce acid reflux may provide a survival benefit, according to…
Lee Schwartzberg FDA approvals

FDA approves Granix injection for self-administration in patients with severe neutropenia

December 26, 2014
The FDA has approved a self-administered injection of the leukocyte growth factor filgrastim for patients with nonmyeloid malignancies, allowing more flexibility for…
More News Headlines »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
Meeting News Coverage Video
Updated clinical data may significantly impact impact treatment of CLL

Updated clinical data may significantly impact impact treatment of CLL

December 27, 2014
SAN FRANCISCO — Jeffrey P. Sharman, MD, medical director of hematology research at US Oncology Research…
More »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
morganatic-roan
morganatic-roan